Neurofeedback and Nomophobia in Young Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction: Given the growing increase in addiction to social networks and smartphone use in young people and its implications for health, it is necessary to investigate effective interventions for the appropriate use of these technologies and coping with possible signs of addiction.

Objective: To evaluate the effect of an intervention based on neurofeedback techniques on anxiety and other disorders associated with problematic use of mobile phones and the internet in young adults.

Methodology: Randomised controlled clinical trial with two parallel groups: an intervention group (IG) and a control group (CG). The study population will be young adults aged 18-30 years. A sample size of 40 participants has been estimated, 20 in each group to detect a difference of 3.9 points or more on the DASS-21 anxiety questionnaire.

All participants will receive an educational workshop on the responsible use of new technologies and the promotion of healthy lifestyles. The IG, in addition to this educational workshop, will receive 25 neurofeedback sessions during 12 weeks, 2-3 sessions/week with the MUSE neurofeedback device.

A baseline and 3-month post-intervention assessment will be conducted for both groups to study change variables related to smartphone addiction (Smartphone Addiction Scale-Short Version (SAS-SV)), nomophobia (Nomophobia Questionnaire (NMP-Q)), depression, anxiety and stress (Depression, Anxiety and Stress Scale 21-item (DASS-21)) and sleep quality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exploring the Impact of Biofeedback on the Inhibitory Control of Healthy Older Adults

NCT04925830

Inhibition

COMPLETED NA

Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder

NCT06361953

Generalized Anxiety Disorder

COMPLETED NA

Functional Near-infrared Spectroscopy for Anxiety Monitoring and Neurofeedback.

NCT05921773

Anxiety Disorders

RECRUITING NA

Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder

NCT04562324

Anxiety Disorder Healthy

UNKNOWN NA

The Relationship Among Electroencephalography,Skin Conductance Response,Heart Rate Variability and Mental Health Among Smartphone Users After Receiving Texting or Calling

NCT04133597

Smartphone Users, Smartphone Addiction, Anxiety, and Skin Conductance

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Biofeedback

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neurofeedback

3 weekly 30-minute neurofeedback sessions per week for 12 weeks

Group Type EXPERIMENTAL

Neurofeedback

Intervention Type OTHER

Conducting neurofeedback sessions guided by a researcher

Control

Health education, a 25-minute session, on mobile phone addiction and promotion of healthy lifestyles

Group Type ACTIVE_COMPARATOR

Health education

Intervention Type OTHER

Health education on mobile phone addiction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurofeedback

Conducting neurofeedback sessions guided by a researcher

Intervention Type OTHER

Health education

Health education on mobile phone addiction

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Biofeedback

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have one or more mobile devices such as smartphones.
* Have a compatible mobile device to install and use the Muse: EEG Meditation \& Sleep application.
* Be fully functional.
* Willingness to voluntarily participate in the study and sign the informed consent form.

Exclusion Criteria

* History of severe psychiatric disorders (such as schizoaffective disorders, bipolar disorder, major depressive episode with symptoms or other non-organic psychotic disorders) requiring psychiatric treatment in the 6 months prior to study entry.
* History of brain injury or other problems contraindicating the use of neurofeedback.

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes